Web Analytics

3 Latest Announced Rounds

  • $90,000,000
    Series A

    2 Investors

    Software Development
    Oct 7th, 2025
  • $1,311,818
    Pre-Seed

    1 Investors

    Renewable Energy Semiconductor Manufacturing
    Oct 7th, 2025
  • $97,716,710
    Series A

    2 Investors

    Biotechnology
    Oct 7th, 2025
$1,088.68M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Trogenix

start up
United Kingdom - Edinburgh, Scotland
  • 07/10/2025
  • Series A
  • $94,323,600

Precision genetic medicines, engineered for change


Related People

Ken MacnamaraFounder

Ken Macnamara United Kingdom - Greater Edinburgh Area

Ken is the Chief Executive Officer of Trogenix, a biotech uniting cutting-edge technologies in genomics, oncology, immunotherapy, and gene therapy to create a revolutionary therapeutic approach.